FORT MILL, SC / ACCESSWIRE / March 9, 2022 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has been notified of a new patent granted by the USPTO covering technology utilized in its VIVO product. The patent, number D980,420 S, entitled "Kit of Positioning Patches", was issued on March 7, 2023. The patent covers technology used in the disposable components of the VIVO product.
David Jenkins, Executive Chairman of RMED, commented, "This newly issued patent joins a robust estate of intellectual property accumulated by our company. For the electrophysiology products, we have now have 36 issued patents and 15 application in process. Additionally, we have 15 patents and patent applications licensed into the company covering the VIVO technology. As a small medical device technology company, we believe the obtaining of IP is critical to our future and to the value of our company. We are quite pleased that another US patent has been granted to us."
About VIVO
Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. VIVO has received marketing clearance from the U.S. FDA and has the CE mark.
About Ra Medical Systems
Ra Medical, and its wholly owned subsidiary Catheter Precision, is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
CONTACTS:
At the Company
David Jenkins
973-691-2000
mhuck@catheterprecision.com
SOURCE: Ra Medical
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。